Tennessee crackdown hits Kalshi, Polymarket and Crypto.com sports contracts — Kalshi says it’s suing

Tennessee crackdown hits Kalshi, Polymarket and Crypto.com sports contracts — Kalshi says it’s suing

Tennessee’s sports betting regulator ordered Kalshi, Polymarket, and Crypto.com to stop offering sports event contracts to state residents and refund customers by Jan. 31. The council warned of fines starting at $10,000 for violations. Kalshi has filed a federal lawsuit, arguing the state lacks authority. Polymarket and Crypto.com have not commented.
12 January 2026
Boeing stock ticks up as investors brace for Tuesday’s delivery report after Airbus update

Boeing stock ticks up as investors brace for Tuesday’s delivery report after Airbus update

Boeing shares rose 1.4% to $237.72 by midday Monday in New York ahead of its annual orders-and-deliveries report due Tuesday. The FAA proposed a new inspection rule for Boeing 737NG jets after reports of wing cracks, with comments open until Feb. 26. Airbus reported 793 deliveries and 889 net orders for 2025. Boeing delivered 537 jets and booked 908 net orders through November.
Apple Picks Google Gemini for Siri — and Alphabet Stock Flirts With $4 Trillion

Apple Picks Google Gemini for Siri — and Alphabet Stock Flirts With $4 Trillion

Alphabet shares rose 0.4% to $329.74 Monday after Apple agreed to integrate Google’s Gemini AI into a redesigned Siri under a multi-year deal. Alphabet’s market value briefly topped $4 trillion, reaching a record high above $334 before pulling back. Apple shares gained 0.6% to $260.95. The move deepens Google’s presence in Apple devices as both firms face regulatory scrutiny.
Archer Aviation stock inches up after securities probe headline; what ACHR investors watch next

Archer Aviation stock inches up after securities probe headline; what ACHR investors watch next

Archer Aviation shares gained 0.7% to $8.87 by midday Monday after Highful Law PLLC announced a securities-fraud investigation tied to a November trade-secret lawsuit from Joby Aviation and a missed Dubai Airshow demo. About 22.5 million shares traded as attention turned to legal risks and Archer’s quarterly results due in late February. Highful said it is gathering information from investors but has not filed a complaint.
12 January 2026
Chevron stock edges up as U.S. flags Venezuela sanctions move; oil prices keep investors cautious

Chevron stock edges up as U.S. flags Venezuela sanctions move; oil prices keep investors cautious

Chevron shares rose 0.4% after U.S. Treasury Secretary Scott Bessent said sanctions on Venezuelan oil could be eased as soon as next week. Traders are moving Venezuelan crude for March delivery and increasing naphtha shipments to boost output. Brent crude fell 0.44% to $63.06 a barrel. Goldman Sachs projects a 2026 oil surplus, keeping its Brent forecast at $56.
Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum Holdings shares fell 5.4% to $332.28 Monday, underperforming a flat U.S. market. The drop followed news that chief accounting officer Matthew Sepe will step down in early February, with Eric Chang set to replace him. Investors are awaiting Lumentum’s Feb. 3 earnings report and conference call. The stock touched an intraday low of $323.24.
Why Recursion Pharmaceuticals (RXRX) stock is up today: a new JPM deck put cash runway back in focus

Why Recursion Pharmaceuticals (RXRX) stock is up today: a new JPM deck put cash runway back in focus

Recursion Pharmaceuticals shares rose 4.4% to $4.87 Monday after an updated investor presentation showed $755 million in cash at year-end 2025 and a projected runway through 2027. The company reported a 43% median reduction in polyp burden for its lead drug REC-4881 in a small trial, with mostly mild to moderate side effects. Recursion will present at the J.P. Morgan Healthcare Conference Tuesday.
Constellation Energy stock dips Monday as Calpine filing details put share supply back in focus

Constellation Energy stock dips Monday as Calpine filing details put share supply back in focus

Constellation Energy shares fell 1.6% to $336.87 late Monday morning, bucking gains in other power producers. The drop follows disclosure of lock-up periods and resale registration rights for former Calpine shareholders after last week’s merger. Constellation also filed to register up to 49.6 million shares tied to the deal. Investors await integration updates and the next earnings date, tentatively set for Feb. 17.
12 January 2026
Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood shares rose 3.6% to $119.38 by late morning Monday, rebounding after an early drop. Bitcoin gained 1.2% to $92,046, while most crypto-linked stocks were steady. Investors are watching Robinhood’s Feb. 10 earnings and regulatory moves against sports event contracts, a sector the company is expanding into. Tennessee and Connecticut regulators have targeted several firms, including Robinhood, over unlicensed sports wagering.
JPMorgan Chase stock slides as Trump’s 10% credit-card rate cap talk hits banks before earnings

JPMorgan Chase stock slides as Trump’s 10% credit-card rate cap talk hits banks before earnings

JPMorgan Chase shares dropped about 2% to $322.59 Monday after President Donald Trump called for a one-year 10% cap on credit card interest rates. Bank stocks broadly fell, with Citigroup down 3.7% and Capital One off 8%. Investors await JPMorgan’s quarterly results Tuesday for updates on consumer credit and card pricing. Trump’s proposal did not include details on enforcement.
12 January 2026
CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

CoreWeave shares climbed 11% to $88.94 in late morning trading Monday after Goldman Sachs began coverage with a Neutral rating and $86 price target. Moody’s projected at least $3 trillion in data-center investment over five years, naming CoreWeave among six major U.S. operators. The Nasdaq 100 was little changed.
AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile shares fell 1.9% to $95.81 Monday after volatile trading, following the December launch of its BlueBird 6 satellite. Investors await the company’s quarterly results in March and updates on satellite deployment. AST aims to launch 45 to 60 satellites by the end of 2026. Other satellite connectivity stocks, including Globalstar and Iridium, rose modestly.
Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Vistra shares rose about 5% Monday after announcing a private offering of senior secured notes maturing in 2031 and 2036. Proceeds will fund the Cogentrix acquisition and repay debt. The company recently signed 20-year nuclear power agreements with Meta for over 2,600 megawatts. Traders are watching note pricing ahead of Vistra’s Feb. 26 earnings report.
12 January 2026
Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla shares rose 0.7% to $448.09 Monday as investors awaited Tuesday’s U.S. inflation report and the company’s Jan. 28 earnings release. Roughly 23.7 million shares traded by late morning. Tesla reported over 434,000 vehicles produced and 418,000 delivered in Q4. Wall Street remains focused on Fed rate moves and Tesla’s progress on autonomy targets.
Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Revolution Medicines shares fell 1.8% to $116.51 in early Monday trading, retreating from last week’s highs after reports of ongoing Merck acquisition talks valuing the company at up to $32 billion. Truist maintained its Buy rating but kept its price target at $99, below the current price. Investors await the company’s presentation at the J.P. Morgan Healthcare Conference later Monday.

Stock Market Today

RTX stock faces Pentagon payout curb list next week as dividend stays in play

RTX stock faces Pentagon payout curb list next week as dividend stays in play

7 February 2026
RTX closed at $198.66 Friday, up 1.4%, after declaring a 68-cent quarterly dividend payable March 19. The Pentagon is expected to name defense contractors early next week that could face limits on dividends and buybacks under a Trump order. RTX’s Raytheon unit has been singled out as “least responsive.” Companies named would have 15 days to submit remediation plans.
Go toTop